Risk factors and prognostic variables in the ovarian hyperstimulation syndrome
- 1 July 1988
- journal article
- research article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 159 (1), 210-215
- https://doi.org/10.1016/0002-9378(88)90523-6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Ultrasonographic and clinical correlates of menotropin versus sequential clomiphene citrate: menotropin therapy for induction of ovulationFertility and Sterility, 1985
- Results of HMG (Humegon)-HCG therapy in 6096 treatment cycles of 2166 Japanese women with anovulatory infertilityEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1985
- Diagnosis-specific serum 17β-estradiol (E2) upper limits for treatment with menotropins using a 125I direct E2 assay**Supported in part by the Pantex Corporation, Santa Monica, California.Fertility and Sterility, 1984
- Induction of ovulation with combined human gonadotropins and dexamethasone in women with polycystic ovarian diseaseFertility and Sterility, 1983
- Monitoring gonadotrophin therapy by real‐time ultrasonic scanning of ovarian folliclesBJOG: An International Journal of Obstetrics and Gynaecology, 1982
- Induction of ovulation with menotropins in women with polycystic ovary syndromeAmerican Journal of Obstetrics and Gynecology, 1981
- Ovarian Hyperstimulation Syndrome: A Current SurveyFertility and Sterility, 1978
- Effect of clomiphene citrate upon amount and duration of human menopausal gonadotropin therapyAmerican Journal of Obstetrics and Gynecology, 1976
- Sequential Use of Clomiphene Citrate and Human Menopausal Gonadotropin in Ovulation InductionFertility and Sterility, 1976
- Pergonal (Menotropins): A Summary of Clinical Experience in the Induction of Ovulation and PregnancyFertility and Sterility, 1970